英文字典中文字典51ZiDian.com

中文字典辞典英文字典 a b c d e f g h i j k l m n o p q r s t u v w x y z

请选择你想看的字典辞典：

单词	字典	翻译
vegr	查看　vegr　在百度字典中的解释	百度英翻中〔查看〕
vegr	查看　vegr　在Google字典中的解释	Google英翻中〔查看〕
vegr	查看　vegr　在Yahoo字典中的解释	Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!

中文字典英文字典工具:

选择颜色:

<style type="text/css">#word104_1 br {display:none;}</style>
<form id="word104_1" method="post" action="http://cpanel.goldgoldprice.com/index.php" target="_blank">
<div style="width: 140px;border:1px solid #000;background-color:#ffffff;padding: 0px 0px;margin: 0px 0px;align:center;text-align:center;overflow:hidden;"><div id="xcolor1_1" style="font-size:12px;color:#183a00;line-height:16px;font-family: arial; font-weight:bold;background:#94abf0;padding: 3px 1px;text-align:center;"><a href="http://cpanel.goldgoldprice.com/" alt="英文字典中文字典" title="英文字典中文字典" id="word_name104_1" style="color:#000000;font-size:14px;text-decoration:none;line-height:16px;font-family: arial;" >英文字典中文字典</a></div><table width=100% style='align:center;text-align:left;font-size:12px;background-color:#ffffff;color:#333333;'>
<tr><td style="text-align:center;border:0"><input type=hidden name="word104_hi" value="1">输入中英文单字</td></tr><tr><td style="text-align:center;border:0"><input type="text" name="word104_input" value="" size=10 style="background-color:#ffffff;color:#000;text-decoration:none;font-family: arial;rial;border:1px solid #999;padding:1px!important;"></td></tr><tr style='line-height: 26px;'><td style="text-align:center;border:0"><input type=submit style="background-color:#ccc;color:#000;border:0 none;cursor:pointer;" value="查询字典"></td></tr></table></div>
</form>

英文字典中文字典相关资料:

List of VEGF VEGFR inhibitors - Drugs. com
VEGR and VEGFR (a tyrosine kinase receptor) signaling modulates angiogenesis, which involves making of new blood vessels from existing blood vessels Abnormal angiogenesis is known to occur in cancer, degenerative eye conditions and other conditions that involve inflammation
Anti-VEGF - Wikipedia
Anti–vascular endothelial growth factor therapy, also known as anti-VEGF ( vɛdʒˈɛf ) therapy or medication, is the use of medications that block vascular endothelial growth factor This is done in the treatment of certain cancers and in age-related macular degeneration
vegr - Wiktionary, the free dictionary
vegr m (genitive vegs or vegar) See the etymology of the corresponding lemma form vegr
Vascular endothelial growth factor signaling in health and disease . . .
Vascular endothelial growth factor (VEGF) signaling is a critical regulator of vasculogenesis, angiogenesis, and lymphangiogenesis, processes that are vital for the development of vascular and lymphatic systems, tissue repair, and the maintenance of homeostasis
Merck Announces Initiation of Pivotal Phase 2b 3 Trial Evaluating MK . . .
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of a pivotal Phase 2b 3 trial evaluating MK-8748 (also known as Tiespectus, EYE201), a novel investigational bispecific antibody that directly activates Tie2 signaling and inhibits vascular endothelial growth factor (VEGF), for the treatment of neovascular (wet) age-related macular
Merck Initiates Pivotal Trial for Investigational Tie2 Agonist VEGF . . .
Merck has announced the initiation of a pivotal Phase 2b 3 clinical trial evaluating MK-8748, also known as Tiespectus, a novel investigational bispecific antibody that directly activates Tie2 signaling and inhibits vascular endothelial growth factor (VEGF) for the treatment of neovascular age-related macular degeneration
Viking Language Dictionary - Vegr
vegr <gen vegar~vegs, pl vegir~vegar, acc vegu~vega> m way, road; mode, manner; direction; side Possible runic inscriptions in Younger Futhark:
Vascular endothelial growth factor signaling in health and disease . . .
Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives Download PDF Review Article Open access Published: 19 May 2025
MSD Announces Initiation of Pivotal Phase 2b 3 Trial . . . - msd. com
RAHWAY, N J , April 2, 2026 – MSD (tradename of Merck Co , Inc , Rahway, N J , USA) (NYSE: MRK) today announced the initiation of a pivotal Phase 2b 3 trial evaluating MK-8748 (also known as Tiespectus, EYE201), a novel investigational bispecific antibody that directly activates Tie2 signaling and inhibits vascular endothelial growth factor (VEGF), for the treatment […]

中文字典-英文字典 2005-2009